The views expressed in this content represent the perspective and opinions of the author and may or may not represent the position of Indiana University School of Medicine.

Author

IU Simon Comprehensive Cancer Center

Indiana University Melvin and Bren Simon Comprehensive Cancer Center is the central hub for cancer research and education across Indiana University. Over the last three decades, its far-reaching discoveries have changed the way cancer is treated around the world. The center’s recent advances in genomics, immunotherapy, bioinformatics, and other sciences are transforming knowledge about cancer prevention, screening, diagnosis and survivorship.

Showing results for IU Simon Comprehensive Cancer Center

IU Simon Comprehensive Cancer Center launches online early detection prevention campaign

A new public education campaign that focuses on cancer early detection and prevention has been launched by the Indiana University Melvin and Bren Simon Comprehensive Cancer Center.

IU Simon Comprehensive Cancer Center | May 16, 2023

chuck pagano holds a microphone onstage at the chuckstrong gala

Chuckstrong raises more than $1.7M for IU cancer research in its 11th year

On a night that celebrated the hope that comes from cancer research, the Chuckstrong initiative raised more than $1.7 million for research at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center.

IU Simon Comprehensive Cancer Center | Apr 22, 2023

Harikrishna Nakshatri, PhD IU Simon Cancer Center

IU cancer researchers identify new target for breast cancer therapy

While trying to understand what initiates breast cells to become cancerous, researchers at the Vera Bradley Foundation Center for Breast Cancer Research at Indiana University Melvin and Bren Simon Comprehensive Cancer Center have identified a new target for breast cancer treatment.

IU Simon Comprehensive Cancer Center | Apr 20, 2023

IU cancer center researcher leads first in-human multiple myeloma study with 90.5 percent response rate

Indiana University Melvin and Bren Simon Comprehensive Cancer Center served as the lead site for a promising first-in-human clinical trial for patients with relapsed multiple myeloma.

IU Simon Comprehensive Cancer Center | Apr 17, 2023

IU cancer center receives American Cancer Society funding for research, education programs

As part of a longstanding partnership, the Indiana University Melvin and Bren Simon Comprehensive Cancer Center has received new and renewed funding from the American Cancer Society to support research and education programs.

IU Simon Comprehensive Cancer Center | Mar 27, 2023

$3.3 million grant to IU researchers aims to increase colorectal cancer screening in rural Indiana

Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center are addressing the low colorectal cancer screening rates in rural Indiana communities with a five-year, $3.3 million grant from the National Cancer Institute.

IU Simon Comprehensive Cancer Center | Mar 23, 2023

$8 million gift establishes research fund, endowed position for bile duct cancer at IU

To create a legacy for his soulmate and to honor their 42-year marriage, IU School of Medicine alumnus Kip E. Virts, MD, has made an $8 million estate gift to support bile duct cancer research at Indiana University Melvin and Bren Simon Comprehensive Cancer Center.

IU Simon Comprehensive Cancer Center | Feb 13, 2023

IU Simon Comprehensive Cancer Center sponsors Indiana racing driver Jackson Lee again in 2023

For the second consecutive season, the Indiana University Melvin and Bren Simon Comprehensive Cancer Center is the primary sponsor of formula car driver Jackson Lee.

IU Simon Comprehensive Cancer Center | Feb 09, 2023

IU cancer researcher identifies new areas in human genomes linked to skin cancer risk

INDIANAPOLIS — An Indiana University cancer researcher has identified eight new genomic regions that increase a person’s risk for skin cancer. Jiali Han, Ph.D., and colleagues discovered eight new loci—locations on a person’s genome—that are susceptible to the development of squamous cell skin cancer. Han is the Rachel Cecile Efroymson Professor in Cancer Research at […]

IU Simon Comprehensive Cancer Center | Feb 18, 2020

IU cancer researcher, collaborators earn $4.1 million grant from Cancer Moonshot

INDIANAPOLIS — A team of researchers from Indiana University and Memorial Sloan Kettering Cancer Center have been awarded a $4.1 million National Cancer Institute “Cancer Moonshot” grant to develop immunotherapy treatments for cancer in children and adolescents, especially those with leukemia. The research promises to achieve more effective, better targeted and less toxic therapies for […]

IU Simon Comprehensive Cancer Center | May 30, 2019